In fact, Treg depletion and blockade of the PD-1/PD-L1 immune checkpoint pathway improved cognitive performance and amyloid-β pathology in experimental models of Alzheimer’s disease [54–56]. This evidence concerns the gene CD274 and early-onset autosomal dominant Alzheimer disease.